For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| (TE) Taxotere and Eloxatin | Participants administered Docetaxel (Taxotere) 75 mg/m² as an 1-hour IV infusion on day 1 followed by Oxaliplatin (Eloxatin) 130 mg/m² as a two to six-hour IV infusion on day 1 per chemotherapy cycle. | None | None | 35 | 78 | 75 | 78 | View |
| (TEF) Taxotere, Eloxatin and 5-fluorouracil | Participants administed with Docetaxel (Taxotere) 50 mg/m² as a 1-hour IV infusion day 1; Oxaliplatin (Eloxatin) 85 mg/m² simultaneously with folinic acid 400 mg/m² as a 2-hour IV infusion, followed by 5-FU 2400 mg/m² as a 46-hour continuous infusion day 1 per chemotherapy cycle. | None | None | 24 | 88 | 87 | 88 | View |
| (TEX) Taxotere, Eloxatin and Xeloda | Participants administered Docetaxel (Taxotere) 50 mg/m² as a 1-hour intravenous (IV) infusion on day 1, Oxaliplatin (Eloxatin) 100 mg/m² as a two to six-hour IV infusion on day 1, Capecitabine (Xeloda) 625 mg/m2 two times a day continuously per chemotherapy cycle. | None | None | 36 | 82 | 77 | 82 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| abdominal pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| dysphagia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| gastric perforation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| intestinal obstruction | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| upper gastrointestinal hemorrhage | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| abdominal pain upper | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| colitis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| enterocolitis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| gastric hemorrhage | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| gastric ulcer perforation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| gastrointestinal hemorrhage | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| ileus | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| inguinal hernia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| intestinal perforation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| mechanical ileus | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| rectal obstruction | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| volvulus | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| febrile neutropenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| anemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| neutropenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| disseminated intravascular coagulation | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| leukopenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| general physical health deterioration | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| pyrexia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| implant site reaction | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| mucosal inflammation | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| performance status decreased | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| asthenia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| chest pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| device occlusion | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| device related infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| gastroenteritis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| abdominal wall abscess | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| bronchopneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| clostridium difficile colitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| device related sepsis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| neutropenic sepsis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| peritoneal abscess | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| sepsis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| septic arthritis staphylococcal | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| staphylococcal sepsis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| pulmonary embolism | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| pleural effusion | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| acute pulmonary edema | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| aspiration | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| dysesthesia pharynx | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| respiratory failure | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| decreased appetite | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| dehydration | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| cachexia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hyperkalemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hyponatremia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| hypovolemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| myocardial infarction | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| cardiac failure | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| cardiac failure congestive | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| cardiopulmonary failure | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| ataxia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| facial paresis | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| peripheral motor neuropathy | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| syncope | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| deep vein thromosis | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| cholecystitis | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| cholecystitis acute | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| hyperbilirubinemia | NON_SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | None | View |
| back pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| spondylolisthesis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| malignant pleural effusion | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| metastases to ovary | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| renal failure acute | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| pyloric stenosis | NON_SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | None | View |
| investigations | NON_SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | None | View |
| hemoglobin decreased | NON_SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | None | View |
| nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| ascites | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| hematemesis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| generalised edema | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| pelvic abscess | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| respiratory arrest | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| stomatitis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| abdominal pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| abdominal pain upper | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| dyspepsia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| neutropenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| febrile neutropenia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| diarrhoea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| dysphagia | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| abdominal distension | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| oral pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| asthenia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| pyrexia | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| oedema peripheral | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| mucosal inflammation | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| oedema | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| peripheral sensory neuropathy | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| neuropathy peripheral | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dysgeusia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| paraesthesia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dizziness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dysaesthesia | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| neurotoxicity | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| alopecia | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| nail disorder | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| skin reaction | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| palmar-plantar erythrodysaesthesia syndrome | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| dry skin | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| decreased appetite | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| dyspnoea | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| cough | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| epistaxis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| oropharyngeal pain | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| hiccups | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| back pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| pain in extremity | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| hypotension | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| insomnia | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| anxiety | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| weight decreased | NON_SYSTEMATIC_ASSESSMENT | Investigations | None | View |